Which of the following acts offers federal financial incentives to commercial and nonprofit organizations for the development of drugs that treat rare diseases?
Orphan Drug Act
Drug Listing Act
Medical Device Amendment
Poison Prevention Packaging Act
Orphan Drug Act
Rationale: The Orphan Drug Act offers federal financial incentives to commercial and nonprofit organizations for the development of drugs that treat rare diseases. Examples of these diseases include Huntington's disease, Tourette syndrome, and muscular dystrophy.
You might also like to view...
A vitamin is an example of a
A) placebo. B) sedative. C) stimulant. D) prophylactic.
The chronic degenerative neuromuscular disease that results in total body paralysis but does not affect mental acuity is ____
A) amyotrophic lateral sclerosis B) multiple sclerosis C) cerebral palsy D) Parkinson's disease
The intertubercular grooveA) is located on the anterior radius
B) is the groove between the olecranon and coronoid processes. C) is a groove between the lateral and medial epicondyles of the distal humerus. D) is a groove separating the greater and lesser tubercles of the humerus.
A patient in ICU develops a supraventricular tachycardia at a rate of 165/min. Which of the following effects would this have on cardiac function?
A. increased end-diastolic volume B. mitral valve regurgitation C. increased stroke volume D. decreased end-diastolic volume